NASDAQ · FLGT
Fulgent Genetics, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for FLGT: Nov 05, 2026
Fulgent Genetics, Inc. Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-1. The reported EPS for the same quarter last year was $-0.16.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-1.00 | $-1.00 | $-1.00 | 1 |
| Dec 2026 | $-1.01 | $-1.01 | $-1.01 | 1 |
| Mar 2027 | $-0.85 | $-0.85 | $-0.85 | 1 |
| Jun 2027 | $-0.56 | $-0.56 | $-0.56 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · MarketBeat · The Motley Fool · BNK Invest- Zacks · Sep 22, 1:16 PM EDTPRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?Precipio and Fulgent Genetics differ in business scope, valuation and growth drivers, but which cancer diagnostics stock looks more compelling now? Let's dive in.
- MarketBeat · Sep 21, 9:45 AM EDTThink Outside the Box With These 3 Companies That Make Unusual Business Models WorkSome of the most successful companies started with business models that likely seemed unusual at first. Investors willing to take a chance on what may appear to be a quirky approach could find a surprisingly strong set of financials and a compelling case for future growth. Three
- The Motley Fool · Aug 7, 10:14 PM EDTFulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- BNK Invest · Jul 31, 4:22 PM EDTNoteworthy Friday Option Activity: OSG, FLGT, LQDAAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Overseas Shipholding Group Inc (Symbol: OSG), where a total of 2,315 contracts have traded so far, representing approximately 231,500 underlying shares. That amounts to
- MarketBeat · Jul 30, 7:04 PM EDTFulgent Genetics Q2 Earnings Call HighlightsCan Fulgent Sustain Sky-High Growth Post-Pandemic? Fulgent Genetics (NASDAQ:FLGT) reported second-quarter 2026 revenue of $85.4 million, up 20% sequentially and 4% from a year earlier, as the company incorporated a full quarter of contributions from Bako Diagnostics and StrataDx.
- Zacks · Jul 30, 6:00 PM EDTFulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Misses Revenue EstimatesFulgent Genetics (FLGT) delivered earnings and revenue surprises of -26.09% and -9.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- The Motley Fool · May 1, 2:26 PM EDTFulgent (FLGT) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · May 1, 8:10 AM EDTFulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Beats Revenue EstimatesFulgent Genetics (FLGT) delivered earnings and revenue surprises of -89.47% and +4.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Apr 30, 6:25 PM EDTiRhythm Holdings, Inc. (IRTC) Reports Q1 Loss, Tops Revenue EstimatesIRHYTHM HLDGS (IRTC) delivered earnings and revenue surprises of +37.78% and +2.87%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- BNK Invest · Feb 27, 3:22 PM ESTNotable Friday Option Activity: FLGT, FHN, ORCLAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Fulgent Genetics Inc (Symbol: FLGT), where a total of 1,532 contracts have traded so far, representing approximately 153,200 underlying shares. That amounts to about 67.
- The Motley Fool · Feb 27, 10:05 AM ESTFulgent Genetics (FLGT) Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Feb 27, 8:15 AM ESTFulgent Genetics, Inc. (FLGT) Q4 Earnings Top EstimatesFulgent Genetics (FLGT) delivered earnings and revenue surprises of +433.33% and -2.39%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Fulgent Genetics, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.